rp2,domvanalimab,etrumadenant,zimberelimab
otsuka,replimune,arcus biosciences,gilead
['rp2 ', 'zimberelimab', 'nsclc', 'domvana', 'sclc', 'lcsm,(-blcsm)', 'arc-7']
 w excellent presentation of arc-7: rp2 of domvanalimab (antitigit) zimberelimab (antipd1) v zim in 1l pdl1h nsclc in asco plenary rapid updates. pfs - hr 0.67 (0.4, 1.13) #asco23 #lcsm 
Chief Scientific Officer, Sarah Cannon Research Institute; Thoracic Medical Oncology, Tennessee Oncology